Biofilms, tolerance and antimicrobial resistance;Bi̇ofi̇lmler, tolerans ve anti̇ṁkrobi̇yal di̇renç

Mikrobiyoloji Bulteni

Volumn 36, Issue 3-4, 2002, Pages 343-351

  Bahar, Gil ^a  

^a SSK Ankara Egitim Hastanesi   (Turkey)

Author keywords

Biofilm; Glycocalyx; Medical device

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BIOFILM; DEVICE; DRUG SENSITIVITY; DRUG TOLERANCE; GLYCOCALYX; IN VITRO STUDY; INFECTION CONTROL; MEDICAL INSTRUMENTATION; REVIEW; BIOLOGICAL MODEL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFECTION; MICROBIOLOGY;

BIOFILMS; DRUG RESISTANCE, MICROBIAL; HUMANS; MODELS, BIOLOGICAL; PROSTHESIS-RELATED INFECTIONS;

EID: 0037495134     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Dunne MW: Bacterial adhesion: Seen any good biofilms lately? Clin Microbiol Rev 2002, 15: 155-166.
2. Hoyle BD, Costerton JW: Bacterial resistance to antibiotics: The role of biofilms. Progress Drug Res 1991, 37: 91-105.
3. Donlan RM, Costerton JW: Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002, 15: 167-193.
4. Spoering AL, Lewis K: Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J Bacteriol 2001, 183: 6746-6751.
5. Stewart PS: Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother 1996, 40: 2517-2522.
6. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: A common cause of persistent infections. Science 1999, 284: 1318-1322.
7. Carpentier B, Cerf O: Biofilms and their consequences, with particular reference to hygiene in the food industry. J Appl Bacteriol 1993, 75: 499-511.
8. Elder M, Stapleton JF, Evans E, Dart JK: Biofilm related infections in ophtalmology. Eye 1995, 9: 102-109.
9. Stickler D: Biofilms. Curr Opin Microbiol 1999, 2: 270-275.
10. Schulin T, Voss A: Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: Limitations of present therapy. Clin Microbiol Infect 2001, 7 (Suppl 4): 1-7.
11. Pascual A: Pathogenesis of catheter-related infections: Lessons for new designs. Clin Microbiol Infect 2002, 8: 256-264.
12. O'Gara JP, Humphreys H: Staphylococcus epidermidis biofilms: Importance and implications. J Med Microbiol 2001, 50: 582-587.
13. Crump JA, Collignon PJ: Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000, 19: 1-8.
14. Anaissie E, Samonis D, Kontoyiannis D, et al: Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995, 14: 135-137.
15. Elliott TS, Moss HA, Tebbs SE, et al: Novel approach to investigate a source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis 1997, 16: 210-213.
16. Donlan RM: Biofilm formation: A clinically relevant microbiological process. Clin Infect Dis 2001, 33: 1387-1392.
17. Ganderton L, Chawla J, Winters C, Wimpenny J, Stickler D: Scanning electron microscopy of bacterial biofilms on indwelling bladder catheters. Eur J Clin Microbiol Infect Dis 1992, 11: 789-796.
18. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW: The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998, 280: 295-298.
19. Shih PC, Huang CT: Effects of quorum-sensing deficiency on Pseudomonas aeruginosa biofilm formation and antibiotic resistance. J Antimicrob Chemother 2002, 49: 309-314.
20. Post JC: Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001, 111: 2083-2094.
21. Lewis K: Riddle of biofilm resistance. Antimicrob Agents Chemother 2001, 45: 999-1007.
22. Suci PA, Mittelman MW, Yu FP, Geesey GG: Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 1994, 38: 2125-2133.
23. Brooun A, Liu S, Lewis K: A dose response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2000, 44: 640-646.
24. Gilbert P, Das J, Foley I: Biofilm susceptibility to antimicrobials. Adv Dent Res 1997, 11: 160-167.
25. Anderl JN, Franklin MJ, Stewart PS: Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000, 44: 1818-1824.
26. Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W: Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob Agents Chemother 2000, 44: 3357-3363.
27. Wilcox MH, Kite P, Mills K, Sugden S: In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm. J Antimicrob Chemother 2001, 47: 171-175.
28. Monzon M, Oteiza C, Leiva J, Amorena B: Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2001, 48: 793-801.
29. Anwar H, Strap JL, Chen K, Costerton JW: Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin. Antimicrob Agents Chemother 1992, 36: 1208-1214.
30. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A: The Calgary biofilm device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999, 37: 1771-1776.
31. Knobloch JKM, Horstkotte MA, Rohde H, Kaulfers PM, Mack D: Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J Antimicrob Chemother 2002, 49: 683-687.
32. Schwank S, Rajacic Z, Zimmerli W, Blaser J: Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother 1998, 42: 895-898.